Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $2.7500 (-4.51%) ($2.7000 - $2.7500) on Tue. Oct. 19, 2021. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 2.97% (three month average) | | RSI | 0 | | Latest Price | $2.7500(-4.51%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | ANPC declines -1.7% a day on average for past five trading days. | | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability)
EDOC(30%) XLU(19%) IVE(15%) SPLV(15%) UUP(14%) | | Factors Impacting ANPC price | ANPC will decline at least -1.485% in a week (0% probabilities).
LIT(-14%) BWX(-14%) REMX(-13%) BNDX(-13%) VIXM(-11%) | | | | | | | | Relative Volatility | | | | | | Market Trend Strength | -1.485% (StdDev 2.97%) | | Hourly BBV | -1.2 () | | Intraday Trend | 0% | | | | | |
|
| 5 Day Moving Average | $2.84(-3.17%) | | 10 Day Moving Average | $2.93(-6.14%) | | 20 Day Moving Average | $0(INF%) | | To recent high | -21% | | To recent low | 0% | | Market Cap | $23m | | | | | | |
Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |